What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study

What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study

(1) Introduction: Since May 2021, sotrovimab has been available in Italy for early treatment of SARS-CoV-2 infection and to prevent disease progression. However, some in vitro studies have questioned its efficacy on Omicron variants. Therefore, we aim to further investigate the efficacy of sotrovima...

Full description

Bibliographic Details
Main Authors: Andrea De Vito, Agnese Colpani, Mariacristina Poliseno, Lucia Diella, Francesco Rosario Paolo Ieva, Alessandra Belati, Roberto Papale, Sergio Babudieri, Laura De Santis, Annalisa Saracino, Sergio Lo Caputo, Giordano Madeddu
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Viruses
Subjects:
sotrovimab
SARS-CoV-2
COVID-19
mortality
disease progression
Online Access:https://www.mdpi.com/1999-4915/15/8/1757

Internet

https://www.mdpi.com/1999-4915/15/8/1757

Similar Items